Evidence map›Paper›PMID 23209318›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

A phospholipase C-γ1-independent, RasGRP1-ERK-dependent pathway drives lymphoproliferative disease in linker for activation of T cells-Y136F mutant mice.

Robert L Kortum, Alexandre K Rouquette-Jazdanian, Michihiko Miyaji, Robert K Merrill, Evan Markegard, John M Pinski, Amelia Wesselink, Nandan N Nath, Clayton P Alexander, Wenmei Li and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Robert L KortumLaboratory of Cellular and Molecular Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Alexandre K Rouquette-Jazdanian
Michihiko Miyaji
Robert K Merrill
Evan Markegard
John M Pinski
Amelia Wesselink
Nandan N Nath
Clayton P Alexander
Wenmei Li
Noemi Kedei
Jeroen P Roose
Peter M Blumberg
Lawrence E Samelson
Connie L Sommers
National Institutes of Health · USNational Cancer Institute · USUniversity of California, San Francisco · US

Funding

Biochemical Basis of T Cell ActivationZIABC010304 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SAMELSON, LAWRENCE · 2009 to 2025
$36.3M
Understand the metabolic fitness of naïve T cellsP01AI091580 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ARTHUR WEISS · 2011 to 2026
$31.1M
Molecular Mechanism of Action of Phorbol EsterZIABC005270 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI BLUMBERG, PETER · 2009 to 2018
$18.4M
Intramural NIH HHS Z99 CA999999NCI NIH HHS Y99 CA999999NIAID NIH HHS P01 AI091580
6 · The paper itself

Abstract

Mice expressing a germline mutation in the phospholipase C-γ1-binding site of linker for activation of T cells (LAT) show progressive lymphoproliferation and ultimately die at 4-6 mo age. The hyperactivated T cells in these mice show defective TCR-induced calcium flux but enhanced Ras/ERK activation, which is critical for disease progression. Despite the loss of LAT-dependent phospholipase C-γ1 binding and activation, genetic analysis revealed RasGRP1, and not Sos1 or Sos2, to be the major Ras guanine exchange factor responsible for ERK activation and the lymphoproliferative phenotype in these mice. Analysis of isolated CD4(+) T cells from LAT-Y136F mice showed altered proximal TCR-dependent kinase signaling, which activated a Zap70- and LAT-independent pathway. Moreover, LAT-Y136F T cells showed ERK activation that was dependent on Lck and/or Fyn, protein kinase C-θ, and RasGRP1. These data demonstrate a novel route to Ras activation in vivo in a pathological setting.

Indexed as

Phospholipase C gammaAdaptor Proteins, Signal TransducingAnimalsCD4-Positive T-LymphocytesDisease ProgressionExtracellular Signal-Regulated MAP KinasesGerm-Line MutationGuanine Nucleotide Exchange FactorsLymphocyte ActivationLymphoproliferative DisordersMAP Kinase Signaling SystemMembrane ProteinsMiceMice, KnockoutMice, Mutant StrainsMice, TransgenicAdaptor Proteins, Signal TransducingExtracellular Signal-Regulated MAP KinasesGuanine Nucleotide Exchange FactorsLat protein, mouseMembrane ProteinsPhospholipase C gammaPhosphoproteinsPlcg1 protein, mouseRasgrp1 protein, mouse

Identifiers

PMID23209318
PMCPMC3529846
OpenAlexW2116399340

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.